This article explores how advanced immune imaging technologies enable real-time visualization of immune responses, improving ...

This article explores how multiomics integration, imaging, and bioinformatics are advancing biomarker discovery, revealing ...

CD4+ T cells, long regarded as supporting actors in cancer immunity, are emerging as central regulators of tumor control and ...

BostonGene, developer of the leading AI foundation model for tumor and the immune biology, today announced it has been honored as the Innovator of the Year at the 2025 Life Sciences Times Vanguard ...

Researchers reviewed evidence linking the vaginal microbiome to pregnancy health and spontaneous preterm birth, highlighting ...

Since its inception, artificial intelligence (AI) has been developed to mimic the adaptation and self-organization of living organisms or biological ...

Head and neck cancer (HNC) represents a significant global health challenge, characterized by aggressive local invasion, frequent recurrence, and poor survival rates. Beyond its physical burden, HNC ...

Researchers at UCLA have discovered a way to dramatically improve how electrical current enters perovskite semiconductors, an emerging class of materials with enormous potential for next-generation ...

Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.

After 30 months of fast-paced innovation in quantum algorithms, six research groups are hoping to hit paydirt. But there can be only one big winner—if there is a winner at all.

Tuberculosis (TB) is the world’s leading cause of death from a single infectious agent, affecting more than 10 million people each year and caused an | Genetics And Genomics ...

With determined leadership and smart use of current and future innovations, we can sustain momentum and accelerate progress toward ending TB.